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for the average linear slope, u 0j and u 1j indicate person-specific random effects for the intercept and slopes respectively, and e ij represents the occasion-specific residuals or measurement error which was allowed to vary with age. 
eAppendix 3 Additional and sensitivity analyses
We examined the characteristics of participants included in analyses of anthropometry compared with those excluded due to missing exposure, outcome or confounder data or loss-to follow-up to better understand the role of selection bias. We examined whether pharmacologic treatment of blood pressure, lipids and HBA1c could have influenced our findings by adding a range of constant values to the risk factor measurements of any individual reporting being on treatment at each time point. We In order to examine whether findings differed by type of hysterectomy, we tested whether the associations of age at period cessation with cardiovascular risk factors differed between women who had hysterectomy with bilateral oophorectomy compared with hysterectomy with conservation of at least one ovary. Trajectories of risk factors were examined in women who could have been pre-or postmenopausal at age 53. Therefore, we performed a sensitivity analysis excluding women who were still pre-menopausal at 53 years, to understand if our findings differed when the analyses were restricted to post-menopausal measures of cardiovascular risk factors. 
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eTable 8 Association of age at period cessation (per year increase) with blood markers from 53 to 69 years, adjusted for co-variates
Legend: HBA1c, glycated haemoglobin; HDL-C, high density lipoprotein cholesterol; HY, hysterectomy; LDL-C, low density lipoprotein cholesterol; NM, natural menopause Note that triglyceride and HBA1c are natural log transformed and all values are in log form. Δ = change per year in risk factor. * P value for the interaction of age and type at period cessation with trajectories. Adjusted for socioeconomic position, parity, time-varying hormone replacement therapy use, age at menarche, BMI at age 36, smoking at age 36, physical activity at age 36. Adjusted for socioeconomic position, parity, age at period cessation, time-varying hormone replacement therapy use, age at menarche, BMI at age 36, smoking and physical activity at age 36. 
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